Elevance Health, Inc. (ELV) Stock Analysis
Recovery setup
Healthcare · Healthcare Plans
Sell if holding. Engine safety override at $373.25: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: Below-average business quality.
Elevance Health is one of the largest U.S. health insurers, serving approximately 45.2 million medical members as of December 31, 2025, as a BCBS licensee in 14+ states and under Wellpoint and Carelon brands. Revenue comes from risk-based premiums (Individual, Employer,... Read more
Sell if holding. Engine safety override at $373.25: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: Below-average business quality. Chart setup: Death cross but MACD improving, RSI 84. Score 4.8/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news boost analyst 0.60, news boost analyst cluster(4), earnings proximity 77d clear, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicCalifornia, New York, Virginia, Indiana, Ohio, Georgia, Florida and Texas10-K Item 1A: 'The states in which we operate with the largest concentrations of revenues include California, New York, Virginia, Indiana, Ohio, Georgia, Florida and Texas'
Material Events(8-K, last 90d)
- 2026-02-26Item 5.02MEDIUMPeter Haytaian will transition from EVP and President of Carelon effective May 4, 2026 to devote more time to family commitments. He will serve as Special Advisor through December 31, 2026 for leadership transition support. No successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
4 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Quality below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $373.25: Quality below floor (3.8 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10. Specifically: Below-average business quality. Chart setup: Death cross but MACD improving, RSI 84. Prior stop was $349.93. Score 4.8/10, moderate confidence.
Take-profit target: $369.31 (-0.8% upside). Prior stop was $349.93. Stop-loss: $349.93.
Target reached (-6.0% upside); Quality below floor (3.8 < 4.0).
Elevance Health, Inc. trades at a P/E of 16.0 (forward 12.9). TrendMatrix value score: 6.8/10. Verdict: Sell.
28 analysts cover ELV with a consensus score of 3.7/5. Average price target: $389.
What does Elevance Health, Inc. do?Elevance Health is one of the largest U.S. health insurers, serving approximately 45.2 million medical members as of...
Elevance Health is one of the largest U.S. health insurers, serving approximately 45.2 million medical members as of December 31, 2025, as a BCBS licensee in 14+ states and under Wellpoint and Carelon brands. Revenue comes from risk-based premiums (Individual, Employer, Medicaid, Medicare) and administrative fees.